|
gptkbp:instanceOf
|
gptkb:chemical_compound
nonsteroidal anti-inflammatory drug
|
|
gptkbp:approvalYear
|
2002
|
|
gptkbp:ATCCode
|
M01AH05
|
|
gptkbp:brand
|
gptkb:Arcoxia
Algix
Etorvel
|
|
gptkbp:CASNumber
|
202409-33-4
|
|
gptkbp:contraindication
|
cerebrovascular disease
ischemic heart disease
severe liver impairment
active peptic ulcer
|
|
gptkbp:developedBy
|
gptkb:Merck_&_Co.
|
|
gptkbp:eliminationHalfLife
|
22 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:hasMolecularFormula
|
C18H15ClN2O2S
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
etoricoxib
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
nonsteroidal anti-inflammatory drug
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
358.84 g/mol
|
|
gptkbp:pregnancyCategory
|
not recommended
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gastrointestinal discomfort
edema
hypertension
|
|
gptkbp:status
|
approved in many countries
not approved in United States
|
|
gptkbp:usedFor
|
osteoarthritis
pain relief
gout
rheumatoid arthritis
ankylosing spondylitis
|
|
gptkbp:bfsParent
|
gptkb:nonsteroidal_anti-inflammatory_drug
gptkb:Arcoxia
|
|
gptkbp:bfsLayer
|
6
|